EP 0585399 A1 19940309 - TREATMENT OF COLORECTAL CARCINOMA WITH ANTISENSE OLIGONUCLEOTIDES TO C-MYB PROTO-ONCOGENE.
Title (en)
TREATMENT OF COLORECTAL CARCINOMA WITH ANTISENSE OLIGONUCLEOTIDES TO C-MYB PROTO-ONCOGENE.
Title (de)
BEHANDLUNG VON KOLOREKTALEN KARZINOMEN MIT ZU C-MYB-PROTOONKOGENEN GEGENSINNIGEN OLIKONUKLEOTIDEN.
Title (fr)
TRAITEMENT DE CARCINOME COLO-RECTAL A L'AIDE D'OLIGONUCLEOTIDES NON CODANTS PAR RAPPORT AU PROTO-ONCOGENE C-MYB.
Publication
Application
Priority
US 70486291 A 19910523
Abstract (en)
[origin: WO9220348A1] Colorectal carcinoma is treated by administering oligonucleotides having a nucleotide sequence complementary to at least a portion of the mRNA transcript of the human c-myb gene. These "antisense" oligonucleotides are hybridizable to the c-myb mRNA transcript.
Abstract (fr)
On traite un carcinome colo-rectal en administrant des oligonucléotides présentant une séquence nucléotidique complémentaire à au moins une partie de la transcription de l'ARNm du gène humain c-myb. Ces oligonucléotides peuvent être hybridés avec la transcription d'ARNm de c-myb.
IPC 1-7
IPC 8 full level
A61K 31/70 (2006.01); A61P 35/00 (2006.01); C07H 21/04 (2006.01); C07K 14/82 (2006.01); C12N 15/09 (2006.01); C12N 15/113 (2010.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61P 35/00 (2017.12); C07K 14/82 (2013.01); C12N 15/1135 (2013.01); A61K 38/00 (2013.01); C12N 2310/3125 (2013.01); C12N 2310/315 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
DOCDB simple family (publication)
WO 9220348 A1 19921126; CA 2109829 A1 19921126; EP 0585399 A1 19940309; EP 0585399 A4 19951115; JP H06508130 A 19940914
DOCDB simple family (application)
US 9204318 W 19920522; CA 2109829 A 19920522; EP 92913962 A 19920522; JP 50031393 A 19920522